抗生素联合经皮引流治疗EVAR后支架感染
本文报告一例75岁男性EVAR后支架感染病例,采用抗生素联合经皮引流治疗,先后两次引流有效,18个月后感染复发再次引流有效,随访一年。提示对不适合切除重建的患者,该方案可作为替代选择。
要点
- EVAR后支架感染标准治疗为切除感染移植物、清创和重建。
- 抗生素联合经皮引流可作为不适合手术患者的替代方案。
- 该病例经两次引流后18个月复发,再次引流仍有效。
核心结论
- 抗生素联合经皮引流对EVAR后支架感染可作为不适合切除重建患者的替代治疗选择。
研究设计与样本
- 个案报告,1例75岁男性EVAR后支架感染患者。
主要发现
- 患者接受抗生素治疗并连续两次经皮引流有效。
- 18个月后感染复发,再次抗生素联合经皮引流有效。
- 治疗后随访一年,门诊随访持续至今。
临床怎么用
- 对不适合切除感染移植物和重建的患者,可考虑抗生素联合经皮引流。
局限性
- 仅为单例个案报告,证据级别有限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Artificial graft infection is one of the most serious complications following EVAR. The gold standard includes the excision of the infected endograft, debridement, and reconstruction. However, these methods are not always the best option for every patient. The authors present the case of a 75-year-old man who was diagnosed with a stent-graft infection following EVAR. A course of antibiotics was administered, and percutaneous drainage was effectively performed twice in succession. After 18 months, the patient was admitted again due to the infection re-occurring. Antibiotics were administered, and percutaneous drainage was effectively re-performed. One year has elapsed since the treatment, and the outpatient followup has lasted until now.
引用
- Zhu F, Ge X, Ci H, et al. Antibiotics and Percutaneous Drainage for Treating Stent-Graft Infection After EVAR. Ann Vasc Surg. 2019. PMID: 31866551. doi:10.1016/j.avsg.2019.12.009
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。